Results 131 to 140 of about 303,632 (262)

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

open access: yesHaematologica, 2018
The purpose of this study was to identify the incidence, causes and impact of non-adherence to oral and subcutaneous chronic treatments for patients with polycythemia vera or essential thrombocythemia.
Ronan Le Calloch   +13 more
doaj   +1 more source

Efficacy and safety of pegylated interferon alpha-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV): results of a phase 2 study after a 7-year median follow-up

open access: yesThe Lancet Haematology, 2017
Background The durability of responses and long-term safety of pegylated interferon alpha-2a (PEG-IFN-a-2a) in patients with polycythemia vera and essential thrombocythemia have not been reported.
L. Masarova   +8 more
semanticscholar   +1 more source

A rare case of extramedullary hematopoiesis: when the pericardium produces blood cells

open access: yesThe Egyptian Heart Journal
Background Cardiac tamponade is an extreme cardiological emergency, fatal in the absence of rapid intervention. This case report highlights a noteworthy and rare correlation between post-polycythemia vera myelofibrosis and extramedullary hematopoiesis ...
SALAH-EDDINE HAYAR   +9 more
doaj   +1 more source

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

open access: yesBlood Cancer Journal, 2018
Polycythemia vera is characterized by the acquisition of the JAK2V617F mutation. Recommended treatments include hydroxyurea and interferon-alpha. Several groups have reported a reduction in the JAK2 mutant allele burden in interferon-treated patients ...
E. Verger   +13 more
semanticscholar   +1 more source

Chronic myelomonocytic leukemia as a transformation from polycythemia vera

open access: yesLeukemia Research Reports, 2019
The hallmark of Polycythemia vera (PV) is the presence of JAK2V617F mutation and increased RBC mass. Chronic myelomonocytic leukemia (CMML) is defined as persistent blood absolute monocyte count (AMC) >/= 1 × 109/L for at least 3 months with myeloid cell
Mirela Andrei   +3 more
doaj   +1 more source

Policitemia vera en un perro : su diagnóstico y su tratamiento [PDF]

open access: yes, 2001
En este artículo presentamos un caso clínico de policitemia vera (eritrocitosis) canina con un nivel de eritropoyetina en suero normal.
Anguiano, E.   +3 more
core  

Biomolecular and histological features in pediatric essential thrombocythemia: adequacy of who diagnostic criteria [PDF]

open access: yes, 2017
Myeloproliferative neoplasms (MPN), Essential Thrombocythemia (ET), Polycythemia Vera (PV) and primary myelofibrosis (PMF), are clonal disorders of the hematopoietic stem cell.
Bertozzi, Irene
core   +1 more source

Subarachnoid hemorrhage and diplopia as initial presentation of polycythemia vera [PDF]

open access: yes, 2005
Christian Opherk   +8 more
core   +1 more source

Polycythemia vera [PDF]

open access: yes, 2020
Misty Dawn Shields, Kenneth S. Zuckerman
  +4 more sources

Home - About - Disclaimer - Privacy